the effect of buprenorphine and methadone in the reduction of methamphetamine craving

comparing the effect of buprenorphine and methadone in the reduction of methamphetamine craving

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT2015112125160N1

Enrollment

Registered

2016-06-04

Start date

2016-02-01

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Methamphetamine Dependency. Mental and behavioural disorders due to use of other stimulants, including caffeine

Interventions

Intervention 1: we will use methadone 40 mg po daily for one group for at least 14 days. Intervention 2: we will use buprenorphine 8 mg po daily for the other group at least 14 days.

Treatment - Drugs

we will use methadone 40 mg po daily for one group for at least 14 days

we will use buprenorphine 8 mg po daily for the other group at least 14 days.

Eligibility

Sex/Gender

Male

Age

18 Years to 50 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Age: 18-50 ;informed consent; methamphetamine dependence Exclusion criteria:Patients unwilling to participate at beginning or during the study; use of another substance except Methamphetamine as of the main substance.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Craving. Timepoint: daily for 14 days. Method of measurement: questionnaire.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactJamshid Ahmadi M.D.

Shiraz University of Medical Sciences

jamshid_ahmadi@yahoo.com+98 71 3627 9319

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 26, 2026